Insider · CIK 0001868209

FLESHNER NEIL E.

Reports to the SEC for 1 company · INDIANAPOLIS, IN

sec.gov

Transactions

Companies

Filings

CIK

0001868209

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Medical Officer	DDisposition to Issuer	−25K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Medical Officer	DDisposition to Issuer	−84.3K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Medical Officer	DDisposition to Issuer	−60.2K sh	—	—	0
2023-12-22	POINT Biopharma Global Inc.U Disposition from Tender	Director, Chief Medical Officer	UDisposition from Tender	−2.77M sh	—	—	0
2023-12-22	POINT Biopharma Global Inc.U Disposition from Tender	Director, Chief Medical Officer	UDisposition from Tender	−233K sh	—	—	0
2023-12-22	POINT Biopharma Global Inc.U Disposition from Tender	Director, Chief Medical Officer	UDisposition from Tender	−358 sh	—	—	0
2023-10-31	POINT Biopharma Global Inc.G Gift	Director, Chief Medical Officer	GGift	−250K sh	—	—	2,773,045
2023-03-28	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director, Chief Medical Officer	AAward	+84.3K sh	—	—	84,257
2022-05-25	POINT Biopharma Global Inc.S Sale	Director, Chief Medical Officer	SSale	−564K sh	$7.51	−$4.24M	3,023,045
2022-03-29	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director, Chief Medical Officer	AAward	+60.2K sh	—	—	60,234
2021-07-06	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director, Chief Medical Officer	AAward	+25K sh	—	—	25,000
2021-06-30	POINT Biopharma Global Inc.A Award	Director, Chief Medical Officer	AAward	+3.59M sh	—	—	3,587,249
2021-06-30	POINT Biopharma Global Inc.A Award	Director, Chief Medical Officer	AAward	+233K sh	—	—	233,171
2021-06-30	POINT Biopharma Global Inc.A Award	Director, Chief Medical Officer	AAward	+358 sh	—	—	358

Recent filings

Accepted (ET)
Dec 274
FLESHNER NEIL E.0001104659-23-129772
SEC(opens sec.gov)
Nov 24
FLESHNER NEIL E.0001104659-23-113897
SEC(opens sec.gov)
Mar 304
FLESHNER NEIL E.0001104659-23-039349
SEC(opens sec.gov)
May 264
FLESHNER NEIL E.0001104659-22-065250
SEC(opens sec.gov)
Mar 314
FLESHNER NEIL E.0001104659-22-041124
SEC(opens sec.gov)
Jul 84
FLESHNER NEIL E.0001104659-21-090253
SEC(opens sec.gov)
Jun 304
FLESHNER NEIL E.0001104659-21-087826
SEC(opens sec.gov)

Companies

POINT Biopharma Global Inc.Director, Chief Medical Officer

Address

4850 WEST 78TH STREET

INDIANAPOLIS, IN, 46268